Posted 1/6/2015 5:26 PM (GMT 0)
A deal being announced today with Genentech points the way for 23andMe, the personal genetics company backed by Facebook billionaire Yuri Milner and Google Ventures, to become a sustainable business.
This opens so many doors for research and it will prove to be one of the most important steps towards truly understanding the genetics behind IBD.
Read more: http://www.forbes.com/sites/matthewherper/2015/01/06/surprise-with-60-million-genentech-deal-23andme-has-a-business-plan/